A set of guidelines for the
treatment of diabetic peripheral neuropathic pain (DPNP) has been published by Mayo Clinic Proceedings. The
guidelines were written by the American Society of Pain Educators. They give medical professionals the first definitive
and consistent strategy for helping diabetics to manage diabetes-related pain. It is estimated that around one million
diabetics suffer from chronic severe DPNP. Up until now, the condition has been under-diagnosed and under-treated. The
new guidelines rank medications according to their effectiveness at treating DPNP. The most effective are termed
first-tier and include duloxetine, oxycodone controlled-release, pregabalin and all tricyclic antidepressants. The
guidelines have been published as a continuing medical education (CME) supplement to Mayo Clinic Proceedings,
April 2006. Go to: www.mayoclinicproceedings.com.Note: The contents of this blog are for informational purposes only and should not be construed as medical advice or substitute for professional care. For medical emergencies, dial 911!
Posts with tag duloxetine
Guidelines developed for diabetes-related pain
A set of guidelines for the
treatment of diabetic peripheral neuropathic pain (DPNP) has been published by Mayo Clinic Proceedings. The
guidelines were written by the American Society of Pain Educators. They give medical professionals the first definitive
and consistent strategy for helping diabetics to manage diabetes-related pain. It is estimated that around one million
diabetics suffer from chronic severe DPNP. Up until now, the condition has been under-diagnosed and under-treated. The
new guidelines rank medications according to their effectiveness at treating DPNP. The most effective are termed
first-tier and include duloxetine, oxycodone controlled-release, pregabalin and all tricyclic antidepressants. The
guidelines have been published as a continuing medical education (CME) supplement to Mayo Clinic Proceedings,
April 2006. Go to: www.mayoclinicproceedings.com.
